Stock Taper
SCREENER COMPARE ANY 2 STOCKS
SNN
SMITH & NEPHEW PLC
NYSE
$28.97
▼ DOWN 0.55% (-0.16)

KEY STATISTICS

Market Cap$12.17 B
52w High$38.79
52w Low$28.56
Dividend Yield2.06%
FrequencySemi-Annual
P/E13.63
Volume1.49M
Shares Out.419.93M

COMPANY

LEADERSHIP

Deepak S. Nath
CHIEF EXECUTIVE
Deepak S. Nath

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 16, 1999
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
18,362

PRICE TARGET

Target High$31.85
Target Low$30.00
Target Median$30.93
Target Consensus$30.93

UPCOMING EARNINGS

DateFeb 23, 2027
DayTuesday
Rev. Est.$3.32B
FEB
23
TUE

SPLIT RECORD

DATETYPERATIO
2014-10-15Forward5:2
2003-12-16Forward2:1
2000-08-07Reverse9:11

PRICE

$28.97 ▼ DOWN 0.55% (−$0.16)
OVERLAYS
$28.80$28.87$28.959:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM28.97

About Smith & Nephew plc

https://www.smith-nephew.com ↗

Smith & Nephew plc develops and sells global medical devices, including joint implants, trauma products, sports medicine, arthroscopic tech, and advanced wound care solutions for healthcare providers.

INDUSTRY

Medical - Devices

A PRODUCT SMITH & NEPHEW PLC IS KNOWN FOR

Tendon Seam™ Rotator Cuff Repair System
Tendon Seam™ Rotator Cuff Repair System

Smith & Nephew's innovative rotator cuff repair system, acquired via Integrity Orthopaedics in January 2026, aims to reduce re-tears and enhance patient outcomes, strengthening its shoulder repair portfolio and driving growth in sports medicine.

COMPETITORS

COMPETITOR
CNMD COMPARE
IART COMPARE
JNJ COMPARE
SYK COMPARE
ZBH COMPARE

Revenue by Products

IconPRODUCTFY2022FY2023FY2024FY2025
Orthopaedics Sports Medicine and ENT and Advanced Wound Management$5.21B $5.55B ▲$5.81B ▲—
Orthopaedics Sports Medicine and Ear Nose and Throat$3.7B $3.94B ▲$4.13B ▲$4.37B ▲
Advanced Wound Management$1.51B $1.61B ▲$1.68B ▲$1.79B ▲

Revenue by Geography

MapREGIONFY2019FY2020FY2021FY2022
United States of America— — $2.66B $2.76B ▲
U$2.55B $2.34B ▼— —
CHINA— — $352M $319M ▼
C$336M $318M ▼— —
G$211M $166M ▼— —

ETFS HOLDING THIS STOCK

ETFS HOLDING
52
LISTED HERE
8
RANKED BY POSITION SIZE
VXUS
0.00% · 764.2K
DFIC
0.06% · 297.7K
AVDE
0.04% · 268.5K
KOMP
0.08% · 78.8K
DTEC
0.92% · 24.7K
SPWO
0.06% · 4.7K
ALRG
0.60% · 1.6K
EMGM.L
0.01% · 106

INSTITUTIONAL OWNERSHIP

SHARES OWNED
5.97%
HOLDERS
452
TOP 12 OF 452 · RANKED BY POSITION SIZE
Bank Of Montreal /Can/
3.3M sh · $119.16M
River Road Asset Management, LLC
3.2M sh · $103.02M
Goldman Sachs Group Inc
3.1M sh · $88.44M
Brandes Investment Partners, LP
2.1M sh · $61.91M
Scharf Investments, LLC
2.0M sh · $73.63M
Morgan Stanley
2.0M sh · $70.83M
Dimensional Fund Advisors LP
1.8M sh · $53.13M
Lmr Partners Llp
1.8M sh · $50.93M
Causeway Capital Management LLC
1.6M sh · $45.09M
Bank Of America Corp /De/
1.4M sh · $46.49M
Todd Asset Management LLC
1.4M sh · $44.28M
Wells Fargo & Company/Mn
1.4M sh · $39.63M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity4
Return On Assets4
Debt To Equity1
Price To Earnings2
Price To Book3
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Lisa McClain
Lisa McClain
Sale (Full)
2025-06-17
 Daniel Goldman
Daniel Goldman
Sale
2023-07-10
 Michael McCaul
Michael McCaul
Sale
2022-09-02

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 1
UNDERWEIGHT 1
HOLD 1
MARKET PERFORM 1
4 GRADES IN THE LAST 12 MONTHS
JP Morgan NEUTRAL Barclays UNDERWEIGHT Canaccord Genuity HOLD Bernstein MARKET PERFORM

SECTORS PEERS

PEERPRICE
CNC$64.75COMPARE
RPRX$60.85COMPARE
THC$266.80COMPARE
ZBH$100.91COMPARE
MEDP$600.65COMPARE
NBIX$154.06COMPARE
COO$71.17COMPARE
FMS$23.10COMPARE